IBI Underwriting: how much capital is really left after dividends, capital reduction and long-term investing
IBI Underwriting paid out about NIS 64 million in 2025 and added another NIS 14.4 million dividend after the balance sheet date, while liquid assets fell to NIS 107.8 million and long term investments jumped to NIS 95.7 million. This follow-up isolates the real question: how much balance sheet firepower is still left for the business.
The main article argued that 2025 profit looked cleaner in the headline than it did in cash or fee terms. This follow-up isolates one layer only: capital allocation. After NIS 64 million already went out in 2025 through dividends and capital reduction, and after more cash was pushed into long duration assets, how much real capital is still left for an underwriting house whose balance sheet is also part of its operating toolkit.
The short answer is less than the balance sheet headline suggests. There is no debt problem here. The company does not borrow from banks or bondholders, and year end equity still stood at NIS 182.2 million, or about 82% of total assets. But the liquid pool shrank sharply. Cash and cash equivalents fell to NIS 42.2 million from NIS 89.6 million, short term investments slipped to NIS 65.6 million from NIS 70.5 million, and total liquid assets dropped to NIS 107.8 million from NIS 160.1 million.
The easiest number to misread is the jump in long term investments, from NIS 40.4 million to NIS 95.7 million. At first glance that looks like more than NIS 55 million moved straight out of liquidity. In cash terms, the actual purchase of long term investments was NIS 28.2 million, while the rest of the increase came mainly from a NIS 27.1 million revaluation. That nuance matters, but it does not make the capital-allocation picture any easier. It sharpens it. The company both paid out capital aggressively and pushed more cash farther out the curve, while also benefiting from accounting profit that did not create liquidity.
The payout chain was more aggressive than the year's profit
The story did not start with the November capital reduction. The company returned capital throughout the year and then added another layer through the court-approved reduction.
| Event | Decision date | Payment or status | Amount |
|---|---|---|---|
| First dividend | March 10, 2025 | Paid on March 27, 2025 | NIS 6.6 million |
| Second dividend | May 25, 2025 | Paid on June 12, 2025 | NIS 9.5 million |
| Third dividend | August 13, 2025 | Paid on September 2, 2025 | NIS 9.1 million |
| Fourth dividend | November 10, 2025 | Paid on November 26, 2025 | NIS 13.8 million |
| Capital reduction | Court approval on November 24, 2025 | Paid on December 10, 2025 | NIS 25.0 million |
| Post balance sheet dividend | March 18, 2026 | Approved out of Q4 2025 profit | NIS 14.4 million |
Cash that actually left during 2025 totaled NIS 64 million. That already exceeded the year's net profit of NIS 46.6 million. Including the dividend approved after the balance sheet date, but clearly tied to fourth quarter 2025 profit, the 2025 cycle reaches NIS 78.4 million of capital return, or about NIS 31.8 million above annual net profit.
That is the key point. The company did not simply distribute current profit. It also used capital reduction to return cash, and then came back in March 2026 with another ordinary dividend. This was not a one off reaction to a strong year. It looks like policy.
What is still liquid, and what is less available than it looks
Even NIS 107.8 million of headline liquidity does not equal NIS 107.8 million of fully free capital. Roughly NIS 41 million of current assets sit in bank deposits. The rest of short term investments is invested mainly in high grade government and corporate bonds. On top of that, about NIS 19.7 million is tied up in securities purchased in connection with underwriting activity, up from NIS 12.3 million a year earlier. In its dedicated liquidity discussion, the company also presents liquid balances of NIS 103.7 million after excluding a NIS 4.1 million trustee deposit required under underwriting regulations.
The other side of the balance sheet matters as well. Current liabilities rose to NIS 24.4 million from NIS 14.9 million, mainly because of higher salary and bonus accruals. If long term employee liabilities are added too, employee related obligations reach about NIS 23.6 million. So the liquid balance is not simply idle surplus cash. Part of it is already tied to operating activity, regulation, and compensation.
That is the core of the read. Equity did not collapse, but it became less flexible. Less of it remained in cash or short assets, and more of it either moved into long term holdings or already went out the door.
Cash bridge: operations did not fund both the payout policy and longer duration investing
The right frame here is all-in cash flexibility, not normalized earning power. The question is not how much cash the business can produce before management choices. The question is how much cash remained after the choices management actually made.
| Item | 2025 | Why it matters |
|---|---|---|
| Cash flow from operations | NIS 33.3 million | This is the cash the business generated in 2025 |
| Purchase of long term investments | NIS 28.2 million | Fresh cash deployed into long duration assets |
| Lease principal repayment | NIS 0.8 million | Non discretionary cash use |
| Dividends paid | NIS 39.0 million | Ordinary cash return during the year |
| Capital reduction paid | NIS 25.0 million | Additional cash return beyond current earnings |
| What remained after all of that | Negative NIS 59.7 million | Operations did not fund the full policy mix |
The gap between that negative figure and the actual cash decline of NIS 47.4 million is explained mainly by a net NIS 14.25 million realization from short term investments. That is exactly the difference between a surface level read and an economic one. Net investing cash outflow looks milder at NIS 15.8 million only because the company sold part of its short dated liquid portfolio while buying longer dated assets. Put differently, operations did not fund the capital-allocation policy. The liquid portfolio funded it.
Why this matters now
For an underwriting house, a liquid balance sheet is not only a safety buffer. It is part of the operating toolkit. It supports the ability to take underwriting commitments, hold securities purchased alongside transactions, and stay flexible when issuance windows reopen. So the real debate is not whether the company can theoretically distribute more cash. It is how much it wants to keep inside the business in order to keep earning from the next market cycle.
The NIS 14.4 million dividend approved on March 18, 2026 shows that management is still leaning toward distribution. That is understandable after a strong year. But that is exactly the point this continuation isolates: the more capital the company keeps sending out while also pushing part of the balance sheet farther out the curve, the smaller the liquid margin of maneuver becomes versus the position it had at the end of 2024.
That point carries extra weight because the stock itself is not very liquid. On April 6, 2026, daily trading turnover was only about NIS 113 thousand. In a name like this, capital left inside the company is part of the thesis rather than background noise. Investors are not only buying an income statement. They are also buying the question of how much internal firepower is still left.
Conclusion
IBI Underwriting did not enter 2026 with a leverage problem. It entered with a smaller liquid pool and a more aggressive capital-allocation posture. Capital is still there, but less of it remains short dated, immediately available and flexible. If 2026 stays strong for underwriting, that posture will look like confidence. If the market cools, the same posture could quickly look like an early reduction in balance sheet firepower.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.